Latest Capital Raising News

QX Resources has renegotiated its lithium brine project options in the US to reduce upfront costs while expanding its footprint, alongside progressing promising gold exploration in Queensland. The company ends the quarter with a modest cash position, underscoring the need for careful capital management.

Titan Minerals Limited has entered an underwriting agreement with CPS Capital Group to cover a $2.8 million options shortfall, ensuring funding for its Dynasty Gold Project and working capital needs.

Industrial Minerals Ltd reports encouraging progress in its High Purity Quartz projects, including promising testwork results and strategic marketing efforts in China, supported by a recent $2.3 million capital raise.

NewPeak Metals has acquired the Allaru Vanadium Project in Queensland, marking a strategic pivot into critical minerals, supported by a planned $2–3 million capital raise via rights issue.

Equity Story Group Ltd (ASX:EQS) reports a robust December quarter marked by significant growth in funds under management, membership fees, and capital markets revenue, alongside strategic cost reductions positioning the company for sustained 2025 growth.

KneoMedia reports a successful quarter marked by significant capital raises and expanding deployments of its KneoScience platform across New York City schools, positioning the company for sustained revenue growth.

Warriedar Resources has nearly doubled its gold resource at the Ricciardo Project to 947.5 koz and uncovered promising antimony mineralisation, backed by strong metallurgical test results and a recent A$9.55 million capital raise.

West Cobar Metals reports significant resource expansions at its Salazar project alongside promising copper-antimony test results at Bulla Park, while aggressively trimming costs to extend its runway.

Zenith Minerals reported a 40% increase in its Dulcie Far North gold resource and secured A$2.48 million in new funding, positioning the company for aggressive exploration across its Australian gold and lithium projects.

Clara Resources outlines key progress on its Ashford Coking Coal Project drilling preparations and details ongoing capital management initiatives, including rights issues and entitlement offers, while navigating boardroom challenges.

DXN Limited reported a robust 58.1% revenue increase to $4.8 million in Q2 FY25, underpinned by strategic capital raising and new product innovation targeting AI infrastructure. The company is advancing key mining and telecom projects while streamlining operations to support its ambitious $16 million revenue guidance for FY25.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.